James Buchanan, PharmD President, Covilance, LLC

Dr. James Buchanan is an independent drug safety consultant. He worked in the area of clinical toxicology at the Bay Area Regional Poison Control Center at San Francisco General Hospital before entering the pharmaceutical industry. Dr. Buchanan began his industry career at Genentech where he worked in the areas of medical information and drug safety in the clinical development department. He subsequently moved to Gilead Sciences to establish a drug safety department, and later started the drug safety department at Tularik Inc. where he acted as Chief Safety Officer until the company was acquired five years later by Amgen.